A Multicenter, Randomized Controlled Phase II Study of Short-Course Radiotherapy Followed by Sequential PD-1 Inhibitor and FOLFOX Chemotherapy Versus Long-Course Chemoradiotherapy for High-Risk Locally Advanced pMMR/MSS Lower Rectal Adenocarcinoma (STAR Trial)
Clinical trial NCT07669220 · RECRUITING
Trial details
- NCT number
- NCT07669220
- Sponsor
- Sixth Affiliated Hospital, Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2028-01-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.